Publication dates

All regions

Bladder Cancer Industry, August 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, therapeutics, more »


 
1-20 of about 8 500 reports for Bladder Cancer

Tengion, Inc. (Symbol:TNGN) SWOT Analysis, Strategy, Revenues and Profits

Tengion, Inc. (Symbol:TNGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... The company's neo-urinary conduit is used for bladder cancer patients, who need urinary diversion. Its neo-kidney augment is used for patients suffering from advanced chronic kidney disease. The company owned ...

Oncology Research Digest H1 2014

Oncology Research Digest H1 2014

  • $ 350
  • Industry report
  • August 2014
  • by TBRC Business Research

... Areas such as biosimilars, novel immunotherapies, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, ovarian cancer and drugs such as rituxan, avastin, herceptin, traceva ...

Bladder Cancer Partnering 2009-2014

Bladder Cancer Partnering 2009-2014

  • $ 695
  • Industry report
  • August 2014
  • by Currentpartnering

... Report contains over 25 links to online copies of actual bladder cancer deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under non muscle invasive bladder cancer ...

 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Drugs that fall under non muscle invasive bladder cancer (nmibc) (superficial bladder cancer). This report provides information on the therapeutic development based on the non muscle invasive bladder ...

Bladder Cancer - Pipeline Review, H2 2014

Bladder Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of bladder cancer- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Bladder Cancer Drug Pipeline Update 2014

Bladder Cancer Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

... bladder cancer drug pipeline update 2014 according to the american cancer society, bladder cancer is the 6th most common cancer in the u.S. bladder cancer occurs among both men and women. When found ...

Bladder Cancer Drug Pathway Analyzer 2014

Bladder Cancer Drug Pathway Analyzer 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the bladder ...

Malignant Mesothelioma - Pipeline Review, H2 2014

Malignant Mesothelioma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... Induced by adi-peg 20 are associated with anticancer activity in bladder cancer and mesothelioma models at aacr annual meeting 2013 96feb 14, 2013: verastem files for orphan disease status for vs-6063 ...

GenomicTree, Inc. - Product Pipeline Analysis, 2014 Update

GenomicTree, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • July 2014
  • by Global Data

... Include multiplex pyroseq test, gtplex braf pyroseq test, gtplex kras pyroseq test, gtplex egfr pyroseq test, gtplex respi pyroseq test, gtplex hpv pyroseq test, oncofinder colon cancer, oncofinder bladder ...

About 600 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Sweden

  • Urinary Bladder Cancer in Wegener's Granulomatosis: Risks and Re...
  • June 2014
    6 pages
  • Bladder Cancer  

    Cancer  

  • Sweden  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.